Target (CBDY) Long-Term Deferred Tax (2020 - 2024)

Target (CBDY) reported Long-Term Deferred Tax of $5.4 million for Q4 2024, up 7.6% quarter-over-quarter from $5.0 million in Q4 2022.

Target (CBDY) Long-Term Deferred Tax (2020 - 2024) Analysis & Trends

Target (CBDY) has 3 years of Long-Term Deferred Tax data on file, last reported at $5.4 million in Q4 2024.

  • Long-Term Deferred Tax for Q4 2024 came in at $5.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $5.4 million (changed N/A YoY), and the FY2024 annual result was $5.4 million, changed N/A from the prior year.
  • Long-Term Deferred Tax climbed to $5.4 million in Q4 2024 per CBDY's latest filing, from $5.0 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $5.4 million in Q4 2024 and troughed at $3.5 million in Q4 2020.
  • A 3-year average of $4.6 million and a median of $5.0 million in 2022 frame the typical range for Long-Term Deferred Tax.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Dec 31, 2024 5.40 Mn
Dec 31, 2022 5.02 Mn
Dec 31, 2020 3.50 Mn